Mizagliflozin and Phloretin in experimental PD

Bergling, Karin, Lund University, https://orcid.org/0000-0003-2483-9495

Martus, Giedre, Lund University

Öberg, Carl, Lund University

karin.bergling@med.lu.se, giedre.martus@med.lu.se, carl.oberg@med.lu.se

Publication date: September 11, 2022

Publisher: Dryad

https://doi.org/10.5061/dryad.x69p8czm8

Citation

Bergling, Karin; Martus, Giedre; Öberg, Carl (2022), Mizagliflozin and Phloretin in experimental PD, Dryad, Dataset, https://doi.org/10.5061/dryad.x69p8czm8

Abstract

Here we tested a selective blocker of sodium glucose co-transporter 1, mizagliflozin, as well as phloretin, a non-selective blocker of facilitative glucose channels in an experimental model of peritoneal dialysis in anesthetized Sprague-Dawley rats.

Funding

Medicinska Fakulteten, Lunds Universitet